Cel-Sci Corporation (CVM)

3.11 +0.09 (+2.98%)

IEX Real-Time Price

March 19, 2019 EST.

NYSE American : Healthcare

Prev Close 3.02

Price Open 3.07

Volume: 212,130

Avg Volume: 245,874

Market Cap: 91.95M

P/E Ratio -1.64

52 Wk Range 0.8165-4.44



CVM Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2019-02-28
26.75M
3.15M
14.27
11.78%

2019-02-15
26.75M
3.06M
11.85
11.45%

2019-01-31
25.58M
2.87M
8.47
11.23%

2019-01-15
25.58M
2.57M
8.79
10.06%




CVM Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-02-14
Q1 2019
N/A
0.00 (0)
-0.17
0.00

2018-12-20
Q4 2018
N/A
0.00 (0)
-0.70
0.00

2018-08-14
Q3 2018
N/A
0.00 (0)
-0.36
0.00

2018-05-15
Q2 2018
N/A
0.00 (0)
-0.31
0.00

News

CEL-SCI'S Phase III Trial In Head & Neck Cancer My Analysis (2019-03-19 12:38 SeekingAlpha)

CEL-SCI (NYSE American:CVM) is an American Oncology Company who is developing therapies to activate the immune system in treating cancer, immune diseases and infectious diseases. CEL-SCI's Multikine is a patented, designated Orphan Drug therapy for treating advanced primary head and neck canceā€¦

 


Statistics

Shares Outstanding: 29.57M

Top 15 Institution Percent: 11.80

Price To Sales: 182.57

Price To Book: 32.98

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -101.51

Return On Equity: 2296.87

Profit Margin: N/A

Price History

Beta: 1.39

50-day Moving Avg: 2.82

200-day Moving Avg: 2.66

YTD Change: 7.61

5-day Change: 2.30

1-month Change: 12.68

3-month Change: 14.76

6-month Change: -18.37

1-year Change: 75.71

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cel-Sci Corporation

Exchange: NYSE American

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cel-sci.com

CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.